Gene Expression of Somatostatin Receptor 4 Predicts Clinical Outcome of Patients with Metastatic Neuroendocrine Tumors Treated with Somatostatin Analogs

CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS

Slaby, O; Sachlova, M; Bednarikova, M; Fabian, P; Svoboda, M; Vytopilova, S; Valik, D; Vyzula, R, 2010: Gene Expression of Somatostatin Receptor 4 Predicts Clinical Outcome of Patients with Metastatic Neuroendocrine Tumors Treated with Somatostatin Analogs. CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS 25(2), p. 237 - 243, doi: 10.1089/cbr.2009.0708

Research Groups:

CEITEC authors: